Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131717) titled 'Development of an Ultrasensitive Detection System for the Human Myeloid Tumor Marker Gene WT1 and Establishment of Its Reference Range' on Sept. 6.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Hospital
Condition:
None
Intervention:
Adult Male Group:None
Adult Female Group:None
Elderly Male Group (65-80 years):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-01-12
Target Sample Size: Adult Male Group:155;Adult Female Group:155;Elderly Male Group (65-80 years):155;Elderly Female Group (65-80 years):155;
Countries of Recruitment:...